We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22B
AUM Growth
-$123M
Cap. Flow
-$1.19B
Cap. Flow %
-5.42%
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$62M
2
UBS icon
UBS Group
UBS
+$49.7M
3
APD icon
Air Products & Chemicals
APD
+$47.3M
4
T icon
AT&T
T
+$44.6M
5
LRCX icon
Lam Research
LRCX
+$39.6M

Top Sells

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$61.6M
2
HCA icon
HCA Healthcare
HCA
+$50.8M
3
GEN icon
Gen Digital
GEN
+$50.7M
4
BAX icon
Baxter International
BAX
+$50.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$49.1M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 16.24%
3 Financials 11.47%
4 Consumer Discretionary 9.38%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNST icon
1001
QuinStreet
QNST
$927M
$582K ﹤0.01%
139,580
VPG icon
1002
Vishay Precision Group
VPG
$1.08B
$576K ﹤0.01%
33,322
VER
1003
DELISTED
VEREIT, Inc.
VER
$571K ﹤0.01%
14,046
+20
+0.1% +$827
DIN icon
1004
Dine Brands
DIN
$462M
$570K ﹤0.01%
12,942
-55,158
-81% -$2.75M
AAP icon
1005
Advance Auto Parts
AAP
$3.53B
$562K ﹤0.01%
4,817
-246
-5% -$33.8K
IWR icon
1006
iShares Russell Mid-Cap ETF
IWR
$55.9B
$558K ﹤0.01%
11,620
IMCG icon
1007
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.88B
$554K ﹤0.01%
18,180
BFYT
1008
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$550K ﹤0.01%
23,396
+784
+3% +$15.6K
NRIM icon
1009
Northrim BanCorp
NRIM
$593M
$544K ﹤0.01%
71,600
MKL icon
1010
Markel Group
MKL
$25.2B
$543K ﹤0.01%
557
-682
-55% -$662K
EPD icon
1011
Enterprise Products Partners
EPD
$83.7B
$542K ﹤0.01%
20,000
+2,553
+15% +$69.2K
GNL icon
1012
Global Net Lease
GNL
$1.87B
$538K ﹤0.01%
24,199
JLL icon
1013
Jones Lang LaSalle
JLL
$15.8B
$537K ﹤0.01%
4,294
+120
+3% +$13.8K
INFY icon
1014
Infosys
INFY
$51B
$534K ﹤0.01%
71,054
-413,222
-85% -$3.1M
MIC
1015
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$533K ﹤0.01%
6,800
+3,000
+79% +$237K
VC icon
1016
Visteon
VC
$2.85B
$531K ﹤0.01%
+5,200
New +$514K
ETR icon
1017
Entergy
ETR
$50.3B
$530K ﹤0.01%
13,800
+5,400
+64% +$209K
AEGN
1018
DELISTED
Aegion Corp
AEGN
$523K ﹤0.01%
23,900
+5,600
+31% +$118K
IBB icon
1019
iShares Biotechnology ETF
IBB
$9.45B
$521K ﹤0.01%
+5,040
New +$496K
BCE icon
1020
BCE
BCE
$20.8B
$518K ﹤0.01%
11,500
+5,100
+80% +$230K
PBA icon
1021
Pembina Pipeline
PBA
$29.3B
$517K ﹤0.01%
15,605
+5,272
+51% +$171K
SEAC
1022
DELISTED
Seachange International Inc
SEAC
$514K ﹤0.01%
9,670
QSR icon
1023
Restaurant Brands International
QSR
$26.2B
$511K ﹤0.01%
8,179
+579
+8% +$34.1K
ALG icon
1024
Alamo Group
ALG
$1.91B
$509K ﹤0.01%
5,600
+1,300
+30% +$108K
ARQ icon
1025
Arq
ARQ
$83.3M
$508K ﹤0.01%
55,432

Similar funds

Axa's Q2 2017 Portfolio in Review

As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Element Solutions worth $22.3M.

  • Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
  • Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
  • Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
  • Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
  • Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
  • Axa opened 101 new positions and closed 125 in Q2 2017.
  • Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.